Navigation Links
Mannatech to Begin Selling Nutritional Supplements in South Africa
Date:2/26/2008

New operation to launch in second quarter of 2008

COPPELL, Texas, Feb. 26 /PRNewswire-FirstCall/ -- Mannatech, Incorporated (Nasdaq: MTEX), a leading developer and provider of dietary supplements and skin care solutions, announced today it will begin selling products in South Africa during the second quarter of this year.

Among these products will be the company's Optimal Health System, which is comprised of Ambrotose -- a patented blend of mixed plant saccharides; AO -- a proprietary antioxidant; PLUS -- an herbal-amino acid; and PhytoMatrix -- the industry's first all-natural multivitamin with concentrated, plant-sourced minerals and standardized phytochemicals.

"We are excited to enter the market in South Africa, which was the first country to grant a patent for the technology related to the formulation of Mannatech's flagship product, Ambrotose," said Mannatech President and CEO Terry Persinger. "South Africa has a rich tradition of using nature's biodiversity to help address quality of life and optimal health. This tradition aligns well with Mannatech products and our emphasis on natural ingredients."

About Mannatech

Mannatech, Incorporated, is a global wellness solutions provider of innovative, high-quality, proprietary nutritional supplements, topical and skin care products, and weight management products sold through independent associates and members located in the United States and the international markets of Canada, Australia, the United Kingdom, Japan, New Zealand, the Republic of Korea, Taiwan, Denmark, and Germany.

Please Note: This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by use of phrases or terminology such as "intend" or other similar words or the negative of such terminology. Similarly, descriptions of Mannatech's objectives, strategies, plans, goals or targets contained herein are also considered forward-looking statements. Mannatech believes this release should be read in conjunction with all of its filings with the United States Securities and Exchange Commission and cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties, and other factors. Some of these factors include, among others, Mannatech's inability to attract and retain associates and members, increases in competition, litigation, regulatory changes, and its planned growth into new international markets. Although Mannatech believes that the expectations, statements, and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-K and Quarterly Report on Form 10-Q, and other filings filed with the United States Securities and Exchange Commission, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release.

Contact Information:

Gary Spinell, Vice President

Investor Relations

972-471-6512

ir@mannatech.com

Corporate website: http://www.mannatech.com


'/>"/>
SOURCE Mannatech, Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Mannatech Names New VP of Regulatory Affairs, Quality Assurance
2. Mannatech to Open Centralized-Management Office in Switzerland
3. Mannatech Hosts Australasian Convention
4. Mannatech Hosts Japan National Convention
5. Mannatech Launches Phase One of New Sales and Training Tools
6. PLC Systems Files IDE Supplement to Begin Pivotal Study of RenalGuard(TM) and Provides Update on Planned Development Timeline
7. XTend Medical (XMDC) Begins Remote Diabetic Telehealth Program
8. Hondros College Expands School of Nursing to Columbus and Dayton; Students Can Begin LPN Education Almost Immediately
9. High blood pressure worsening in all states for women; begins to stagnate for men
10. Parental Alienation Awareness Organization Begins Preparations for Parental Alienation Awareness Day - April 25th
11. A New Beginning for Medicare Beneficiaries in North Carolina
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... ... January 23, 2017 , ... ... Living (IHCA/INCAL), will serve as a healthcare industry expert at the 2017 Sector ... discussion, moderated by Inside Indiana Business host Gerry Dick, will feature an employer ...
(Date:1/23/2017)... Greifensee, Switzerland (PRWEB) , ... January 23, 2017 ... ... many lab and production applications. However, choosing the right method is paramount to ... may occur more often in situations where multiple persons use the same equipment. ...
(Date:1/23/2017)... ... 23, 2017 , ... "ProRandom is a set of camera tools that allow video editors to ... Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. , With ... with video footage. ProRandom works by using a virtual camera to create the illusion ...
(Date:1/23/2017)... (PRWEB) , ... January 23, ... ... Education Foundation (OREF), in partnership with the American Society of Anesthesiologists® (ASA®), ... Foundation (APSF), the American Academy of Orthopaedic Surgeons (AAOS) and the Cigna ...
(Date:1/23/2017)... , ... January 23, 2017 , ... “The Inn at the Mill”: a story ... fears in her quest to become happy and content. , “The Inn at the ... has also lived in Germany and Vermont and is now living in Berks County on ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... January 23, 2017 Ahead of today,s trading ... how they have fared at the close: Kite Pharma Inc. (NASDAQ: ... OVAS ), and Regeneron Pharmaceuticals Inc. (NASDAQ: ... were relative laggards on Friday, January 20 th , 2017, down ... research reports on these stocks now at: ...
(Date:1/23/2017)... , January 23, 2017 A new ... Testing Market was valued at US$0.53 bn in 2013 and ... a strong 17.50% CAGR between 2014 and 2022. The title of ... Analysis, Size, Volume, Share, Growth, Trends and Forecast 2014 - 2022." ... Non-invasive prenatal testing ...
(Date:1/23/2017)... The global  anxiety disorders and depression treatment market  is expected to reach ... worldwide is anticipated to drive the market growth in the coming years. Increasing ... in the recent years. Continue Reading ... ... ...
Breaking Medicine Technology: